Added to YB: 2023-12-18
Pitch date: 2023-12-18
AVRO [bullish]
AVROBIO, Inc.
+6.87%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
As of June 20, 2024, AVROBIO, Inc. was acquired by Tectonic Therapeutic, Inc., in a reverse merger transaction.
Market Cap
$62.9M
Pitch Price
$15.72
Price Target
N/A
Dividend
N/A
EV/EBITDA
0.58
P/E
2.08
EV/Sales
N/A
Sector
Biotechnology
Category
value
Show full summary:
$AVRO has a low valuation and may be wrapping up strategic alternatives
$AVRO bizarrely cheap: <$60M MC vs $105M cash. Q3 kitchen sink w/ separation charges & license termination, Q4 burn to be low. More Oct layoffs. No value for assets, worst case priced in. Strat alternatives may wrap soon. Upside in most scenarios.
Read full article (1 min)